Monte Rosa Therapeutics News

Monte Rosa Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 10 16:29 ET

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(10.2%)

Apr 10 13:02 ET

Monte Rosa Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 14 16:11 ET

Monte Rosa Therapeutics | 10-K: Annual report

Mar 14 07:48 ET

Monte Rosa Therapeutics | 8-K: Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Mar 14 07:08 ET

Monte Rosa Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Baker Bros. Advisors LP(9.8%),Baker Bros. Advisors (GP) LLC(9.8%), etc.

Feb 14 17:46 ET

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%), etc.

Feb 14 15:09 ET

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.7%)

Feb 14 11:27 ET

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(9.9%)

Feb 14 10:20 ET

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(9.1%),Behzad Aghazadeh(9.1%)

Feb 14 09:17 ET

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(11.056%),Abigail P. Johnson(11.056%)

Feb 9 09:30 ET

Monte Rosa Therapeutics | 8-K: Current report

Jan 8 00:00 ET

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dunn Edmund

Jan 4 00:00 ET

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wallace Owen B.

Jan 4 00:00 ET

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warmuth Markus

Jan 4 00:00 ET

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jones Jullian G

Jan 4 00:00 ET

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Janku Filip

Jan 4 00:00 ET

Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(13.7%),Versant Ventures VI GP, L.P.(13.7%), etc.

Nov 9, 2023 17:26 ET

Monte Rosa Therapeutics: Q3 2023 Earnings Report

Nov 9, 2023 16:04 ET

Monte Rosa Therapeutics | 8-K: Monte Rosa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 9, 2023 07:27 ET